DE602005026287D1 - Anti-gluten-eigelb-antikörper zur behanldung von zoeliakie - Google Patents

Anti-gluten-eigelb-antikörper zur behanldung von zoeliakie

Info

Publication number
DE602005026287D1
DE602005026287D1 DE602005026287T DE602005026287T DE602005026287D1 DE 602005026287 D1 DE602005026287 D1 DE 602005026287D1 DE 602005026287 T DE602005026287 T DE 602005026287T DE 602005026287 T DE602005026287 T DE 602005026287T DE 602005026287 D1 DE602005026287 D1 DE 602005026287D1
Authority
DE
Germany
Prior art keywords
gluten
zoeliakie
treatment
egg
yellow antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005026287T
Other languages
English (en)
Inventor
Hoon Sunwoo
Jeong S Sim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Alberta
Original Assignee
University of Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Alberta filed Critical University of Alberta
Publication of DE602005026287D1 publication Critical patent/DE602005026287D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602005026287T 2004-04-16 2005-04-18 Anti-gluten-eigelb-antikörper zur behanldung von zoeliakie Active DE602005026287D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52139404P 2004-04-16 2004-04-16
PCT/CA2005/000593 WO2005099753A1 (en) 2004-04-16 2005-04-18 Anti-gluten egg yolk antibodies for the treatment of celiac disease

Publications (1)

Publication Number Publication Date
DE602005026287D1 true DE602005026287D1 (de) 2011-03-24

Family

ID=35149778

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005026287T Active DE602005026287D1 (de) 2004-04-16 2005-04-18 Anti-gluten-eigelb-antikörper zur behanldung von zoeliakie

Country Status (6)

Country Link
US (1) US7854942B2 (de)
EP (1) EP1765395B1 (de)
AT (1) ATE497782T1 (de)
CA (1) CA2561800C (de)
DE (1) DE602005026287D1 (de)
WO (1) WO2005099753A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071101B2 (en) * 2005-11-03 2011-12-06 Avaxia Biologics, Inc. Antibody therapy for treatment of diseases associated with gluten intolerance
US8883133B2 (en) 2005-11-14 2014-11-11 Valorisation-Recherche Limited Partnership Pharmaceutical compositions comprising polymeric binders with non-hydrolysable their use in treating celiac disease
CA2667524C (en) * 2006-10-25 2017-02-07 Wisconsin Alumni Research Foundation Methods of reducing phosphate absorption
US8282928B2 (en) * 2007-05-30 2012-10-09 The Governors Of The University Of Alberta Anti-gluten egg yolk antibodies for the treatment of celiac disease
WO2009020748A2 (en) 2007-07-16 2009-02-12 Avaxia Biologics, Inc. Antibody therapy for modulating function of intestinal receptors
EP2725035A1 (de) 2007-10-02 2014-04-30 Avaxia Biologics, Inc. Antikörpertherapie zur Verwendung im Verdauungstrakt
WO2012016429A1 (en) * 2010-08-03 2012-02-09 Asia Hepato Gene Co. Compositions and methods for treating hepatitis virus infection
KR101024297B1 (ko) * 2010-08-11 2011-03-29 유익종 유산 발효에 의해 계란단백질의 항원성이 저하된 유산발효계란 및 그의 제조방법
JP6652353B2 (ja) * 2015-09-09 2020-02-19 任天堂株式会社 通信装置および電池蓋
US10362573B2 (en) * 2015-11-27 2019-07-23 Telefonaktiebolaget Lm Ericsson (Publ) Method and system for multi-protocol transmissions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4550019A (en) 1978-03-22 1985-10-29 South Africa Inventions Development Corporation Manufacture and use of fowl egg antibodies
US4357272A (en) 1978-03-22 1982-11-02 The South African Inventions Development Corporation Recovering purified antibodies from egg yolk
US4748018A (en) 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US5849349A (en) 1982-06-03 1998-12-15 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
ES2052496T3 (es) 1985-11-25 1994-07-16 Ghen Corp Sustancia que contiene anticuerpo especifico obtenida de huevos y metodo para su produccion y uso.
US5367054A (en) * 1993-04-12 1994-11-22 Stolle Research & Development Corp. Large-scale purification of egg immunoglobulin
AU729502B2 (en) * 1996-10-02 2001-02-01 Ovimmune, Inc. Oral administration of chicken yolk antibodies to treat disease
EP0905518A1 (de) 1997-09-23 1999-03-31 Academisch Ziekenhuis Leiden Peptiden spezifisch für Glutenempfindliche T-Zellen und Verwendung davon
GB9814892D0 (en) 1998-07-10 1998-09-09 Kennedy Rheumatology Inst Treatment of celiac disease
GB0212885D0 (en) 2002-06-05 2002-07-17 Isis Innovation Therapeutic epitopes and uses thereof

Also Published As

Publication number Publication date
US20080003263A1 (en) 2008-01-03
US7854942B2 (en) 2010-12-21
ATE497782T1 (de) 2011-02-15
EP1765395B1 (de) 2011-02-09
WO2005099753A1 (en) 2005-10-27
CA2561800C (en) 2011-10-18
CA2561800A1 (en) 2005-10-27
EP1765395A4 (de) 2008-06-18
EP1765395A1 (de) 2007-03-28

Similar Documents

Publication Publication Date Title
DE602005026287D1 (de) Anti-gluten-eigelb-antikörper zur behanldung von zoeliakie
Mine et al. Comparative studies on antigenicity and allergenicity of native and denatured egg white proteins
Kovacs-Nolan et al. Immunochemical and structural analysis of pepsin-digested egg white ovomucoid
Ahmed et al. Immunomodulatory effect of laccase/caffeic acid and transglutaminase in alleviating shrimp tropomyosin (Met e 1) allergenicity
Liu et al. Allergenicity and oral tolerance of enzymatic cross-linked tropomyosin evaluated using cell and mouse models
DE602006016444D1 (de) Babynahrung mit hydrolisierten proteinen
CY1114855T1 (el) Αντισωματα και μορια που προερχονται απο αυτα που δεσμευονται στις πρωτεϊνες toy steap-1
US11291221B2 (en) Methods for determination of bioactivity, quantity, removal, or inactivation of cereal amylase trypsin inhibitors in cereals, flours, plants, and complex foods
CY1121332T1 (el) Μiμhtiκα καλσιτονινης προς θεραπεια ασθενειων και διαταραχων
EA200700136A1 (ru) Анти-cd154-антитела
DK2280721T3 (da) Indoleamin-2, 3-dioxygenasebaseret immunterapi
WO2009034315A3 (en) Vaccine
Ahmed et al. Enzymatic crosslinking and food allergenicity: A comprehensive review
DE69837337D1 (de) Herstellung von proteinen in eiern
EA200900738A1 (ru) Слитые белки, содержащие антигены отторжения опухоли ny-eso-1 и lage-1
TR201905375T4 (tr) Vicia faba proteinli gıda ürünleri.
EA200100668A1 (ru) Индуцируемые пищей, антисекреторные белки в яичном желтке
Kazem-Farzandi et al. β-lactoglobulin mutation Ala86Gln improves its ligand binding and reduces its immunoreactivity
Román‐Carrasco et al. Bos d 13, A Novel Heat‐Stable Beef Allergen
WO2015168416A1 (en) Methods for determination of bioactivity, removal, or inactivation cereal amylase trypsin inhibitors in cereals, flours and complex foods
Li et al. Purification and characterization of parvalbumin isotypes from grass carp (Ctenopharyngodon idella)
EP3947412A4 (de) Entaromatisiertes eiweissisolat, mit proteinisolaten hergestellte produkte und verfahren zu deren herstellung
Peñas et al. Clinical monosensitivity to salmon and rainbow trout: a case report.
Hirose et al. Oligoclonal enzyme-linked immunosorbent assay capable of determining the major food allergen, ovomucoid, irrespective of the degree of heat denaturation
Castroa et al. Proteomic analysis of food allergens